• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 69
      CPX‐351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on? - 21 day(s) ago

      CPX-351 has similar efficacy but more toxicity compared to venetoclax+hypomethylating agent therapy.

      Source: onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on? |American Journal of Hematology | Blood Research Journal | Wiley Online Library https://t.co/O2xv64DhUA https://t.co/JMYaIF9eEs

    • Mashup Score: 7
      ADCETRIS® and ECADD Combination Approved in EU for Hodgkin Lymphoma - 23 day(s) ago

      Learn about the European Approval of Takeda’s ADCETRIS® in newly diagnosed Stage IIb/III/IV Hodgkin lymphoma with chemotherapy, based on Phase 3 HD21

      Source: www.takeda.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD https://t.co/Toc33lt2I0

    • Mashup Score: 25
      Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old - 23 day(s) ago

      Recent molecular and diagnostic advances in acute myeloid leukemia (AML) have led investigators and clinicians to further categorize patients in different

      Source: ashpublications.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old https://t.co/C2cq4KimWW #leusm https://t.co/mOsJebCc1K

    • Mashup Score: 28
      The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment - 23 day(s) ago

      Recent molecular and diagnostic advances in acute myeloid leukemia (AML) have led investigators and clinicians to further categorize patients in different

      Source: ashpublications.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment https://t.co/d9yUnS5ZMI #leusm https://t.co/drPpdqzDhf

    • Mashup Score: 72
      TP53-mutated acute myeloid leukemia: how can we improve outcomes? - 23 day(s) ago

      Recent molecular and diagnostic advances in acute myeloid leukemia (AML) have led investigators and clinicians to further categorize patients in different

      Source: ashpublications.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        TP53-mutated acute myeloid leukemia: how can we improve outcomes? https://t.co/u0YyP7vVig #leusm https://t.co/0WTwmHDoLN

    • Mashup Score: 17
      Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children | NEJM - 23 day(s) ago

      B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among chi…

      Source: www.nejm.org
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        De-escalation of the chemotherapy backbone by replacing the most intensive phases with blinatumomab: Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children https://t.co/vrJuAaD3Ci https://t.co/HXyIpyhWBE

    • Mashup Score: 132
      Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management - 25 day(s) ago

      Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treat…

      Source: onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management https://t.co/tQojXGWoZl #lymsm https://t.co/QTBBoB14CP

    • Mashup Score: 130
      Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management - 25 day(s) ago

      Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treat…

      Source: onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management https://t.co/tQojXGWoZl #lymsm https://t.co/QTBBoB14CP

    • Mashup Score: 130
      Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management - 25 day(s) ago

      Disease Overview Primary cutaneous lymphomas are a rare and heterogeneous group of extranodal lymphomas that require the integration of clinical and histopathologic data for classification and treat…

      Source: onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management https://t.co/tQojXGWoZl #lymsm https://t.co/QTBBoB14CP

    • Mashup Score: 34
      The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B‐cell precursor acute lymphoblastic leukaemia in measurable residual disease‐negative remission - 25 day(s) ago

      Blinatumomab consolidation was recently approved for patients with acute lymphoblastic leukaemia (ALL) who achieve measurable residual disease (MRD) negative remission based on the survival benefit y…

      Source: onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	smbenlazar
        smbenlazar

        The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission https://t.co/LRZIUkHQpH #leusm https://t.co/MW7tPnr9YY

    Load More

    Benlazar S M A

    @smbenlazar

    Professor of hematology, Universitary hospital of Sidi Bel Abbés. Head, Hospitalisation and Geriatric Unit.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings